The presentation will cover the successful implementation at scale across England of:
The NHS Diabetes Prevention Programme, with over two million people with prediabetes now referred in, and published evaluations demonstrating reduced incidence of type 2 diabetes among programme participants as well as at English population level associated with programme implementation.
The NHS Type 2 Diabetes Path to Remission Programme, with over 50,000 people with recent-onset type 2 diabetes now referred in, and published data demonstrating a type 2 diabetes remission rate of 30% at 12 months.
The presentation will also cover how the cases for investment for both programmes were successfully made, how the programmes were established, and how they were rolled out across the whole of England.
Professor Jonathan Valabhji’s visit is funded through a CIHR Knowledge Mobilization in Diabetes Prevention and Treatment Grant awarded to Dr. Kaberi Dasgupta and colleagues.
Biography for Professor Jonathan Valabhji:
Professor Jonathan Valabhji is Clinical Chair in Medicine at Imperial College London, London, UK; Honorary Consultant Diabetologist at Chelsea & Westminster Hospital NHS Foundation Trust in London, UK; and National Specialty Advisor for Multiple Long-Term Conditions at NHS England. From April 2013 until September 2023 he was National Clinical Director for Diabetes and Obesity for the NHS in England. He has led rapid translation of high-quality research into national policy and practice and has established models for evaluation to assess translational impact. He qualified in 1990 from St Bartholomew’s Hospital Medical College, London, UK. In 2019 he was awarded OBE in the Queen’s New Year Honours List for services to diabetes and obesity care.
Please note, this event is being offered both in person at Womens College Hospital and virtually. You can determine the mode in which you will participate when selecting your ticket.
Audience: Attendance is open to U of T faculty, trainees, students, and all Network for Healthy Populations community partners.
